May 9 (Reuters)-
Kissei Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 71.71 71.29 73.20 35.50
(+0.6 pct) (+1.7 pct) (+2.1 pct) (-0.9 pct)
Operating 8.49 10.27 9.00 3.70
(-17.4 pct) (+23.3 pct) (+6.0 pct) (-17.3 pct)
Recurring 9.64 11.35 10.00 4.20
(-15.1 pct) (+7.3 pct) (+3.8 pct) (-13.6 pct)
Net
Net 7.73 8.17 7.80 3.15
(-5.4 pct) (+14.0 pct) (+1.0 pct) (-19.0 pct)
EPS 158.74 yen 166.89 yen 161.43 yen 65.19 yen
Ann Div 46.00 yen 44.00 yen 48.00 yen
-Q2 Div 23.00 yen 22.00 yen 24.00 yen
-Q4 Div 23.00 yen 22.00 yen 24.00 yen
NOTE - Kissei Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T
((Tokyo Headline News Desk +813 6441 1812))